Podimetricsan organization that helps sufferers with diabetes stop critical issues, is teaming up with HealthMed, an worker well being and wellness platform.
HealthMed goals to combine Podimetrics’ SmartMat know-how into its portfolio of advantages meant for giant employers, hospitals and municipalities. The corporate additionally offers worker wellness and psychological well being packages.
Podimetrics’ SmartMat measures the foot temperature of high-risk sufferers and scans for early indicators of irritation that would result in wounds, amputations and diabetic foot ulcers.
“Our partnership with HealthMed is a robust collaboration, and we’re excited to work collectively to help people with advanced diabetes who’re on the best threat for critical issues,” Dr. Jon Bloom, CEO of Podimetrics, stated in an announcement.
“We share a standard mission to deal with prevention and enhance well being outcomes. This collaboration is aimed toward reaching that objective collectively.”
Tracy Webster, founding father of HealthMed, stated the partnership with Podimetrics and its progressive answer for managing difficult diabetes will profit self-insured employers and enhance the continuum of care.
“We sit up for the optimistic influence we will make on well being outcomes and the general value of care,” Webster stated in an announcement.
THE LARGER TREND
In March, Podimetrics partnered with profit administration group Alivi Well being, which included SmartMat know-how into its portfolio of specialty advantages to bolster its podiatry advantages for well being plans and payers.
In 2024, Podimetrics sued Eire-based Bluedrop Medical for patent infringement. Bluedrop has a tool that permits an individual with diabetes to scan their ft for potential cases of foot ulcers.
Based on the compliant, Bluedrop allegedly “straight and/or by way of subsidiaries, workers, intermediaries or commerce names” dedicated acts of infringement by “importing, providing to promote and promoting an instrumentality that infringes [Podimetrics’] Patents-in-Go well with.” The case was dismissed after Podmetrics withdrew its declare.
In 2022, Podimetrics scored $45 million in a Sequence C financing spherical. The capital was used to develop Podimetrics’ product improvement and analysis groups in addition to enhance the variety of companies supplied by its nurse help groups.
In 2019, Podimetrics raised $13.4 million in Sequence B funding. Rock Well being, Norwich Ventures and Scientific Well being Growth participated within the spherical.
Different firms within the diabetes area embrace Dexcom, which in 2024 made a $75 million strategic funding in health-tracking ring maker Oura and established a strategic partnership to allow two-way knowledge circulate between Dexcom’s steady glucose monitor (CGM) and the Oura Ring. Dexcom’s $75 million funding introduced Oura’s valuation to greater than $5 billion.
Diabetes and insulin administration software program firm Glytec and pharmaceutical agency Roche joined forces final yr to permit using Glytec’s software program in reference to Roche’s point-of-care smart-device hospital blood glucose system cobas pulse within the U.S. and international markets.
Based on Roche, cobas pulse’s strip structure offers lab-like outcomes and lowers the necessity to repeat exams. The system can be utilized on all affected person populations, together with neonates and intensive care sufferers.
